COAG
Hemab Therapeutics Holdings
$39.88
−$4.62 (−10.38%)Sep 10, 2026
Key metrics
The numbers that frame COAG today
- Market cap
- $1.86B
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for COAG
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about COAG
Is Hemab Therapeutics Holdings a good buy?
Hold. There is not enough rank data to make a clear call.
What is the market capitalization of COAG?
Hemab Therapeutics Holdings's market capitalization is $1.86B.
Does COAG stock pay dividends?
Hemab Therapeutics Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for COAG?
Hemab Therapeutics Holdings's Debt / Equity ratio is 0.